Prevalence of and risk factors for non-alcoholic fatty liver disease in a non-obese Japanese population, 2011-2012.
about
Pharmacological treatments for non-alcohol related fatty liver disease (NAFLD): a network meta-analysisSystematic review with meta-analysis: risk factors for non-alcoholic fatty liver disease suggest a shared altered metabolic and cardiovascular profile between lean and obese patientsNAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk.Evaluation of the fatty liver index as a predictor for the development of diabetes among insurance beneficiaries with prediabetes.S100A9: A Potential Biomarker for the Progression of Non-Alcoholic Fatty Liver Disease and the Diagnosis of Non-Alcoholic Steatohepatitis.The Impact of PNPLA3 rs738409 Genetic Polymorphism and Weight Gain ≥10 kg after Age 20 on Non-Alcoholic Fatty Liver Disease in Non-Obese Japanese IndividualsCholesterol induces lipoprotein lipase expression in a tree shrew (Tupaia belangeri chinensis) model of non-alcoholic fatty liver disease.Neck circumference as an independent indicator to non-alcoholic fatty liver disease in non-obese men.Prevalence of and risk factors for non-alcoholic fatty liver disease in a Chinese population: An 8-year follow-up studyEthnicity matters: A Systematic Review and Meta-Analysis of the Non-Linear Relationship Between Alcohol Consumption and Prevalence and Incidence of Hepatic SteatosisLean NAFLD: An Underrecognized Outlier.Alcohol consumption and risk of fatty liver disease: a meta-analysis.Pharmacological interventions for non-alcohol related fatty liver disease (NAFLD): an attempted network meta-analysis.Nonalcoholic fatty liver disease in Asia: emerging perspectives.Effect of curcumin on visfatin and zinc-α2-glycoprotein in a rat model of non-alcoholic fatty liver disease.Combination of PNPLA3 and TLL1 polymorphism can predict advanced fibrosis in Japanese patients with nonalcoholic fatty liver disease.Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.Efficacy of nanocurcumin supplementation on insulin resistance, lipids, inflammatory factors and nesfatin among obese patients with non-alcoholic fatty liver disease (NAFLD): a trial protocol.Biphasic effect of alcohol intake on the development of fatty liver disease.Risk for development of severe liver disease in lean patients with nonalcoholic fatty liver disease: A long-term follow-up study.Green cardamom increases Sirtuin-1 and reduces inflammation in overweight or obese patients with non-alcoholic fatty liver disease: a double-blind randomized placebo-controlled clinical trialThe fatty liver index (FLI) and incident hypertension: a longitudinal study among Chinese population
P2860
Q24186865-FE5EFFA0-C086-46D0-BDBC-8A71B81A3FB7Q29994538-8E51B71D-9511-46BF-9C77-CC0FD8190D27Q33844463-6331B04A-8FF3-4B64-8AF5-41F2683008ABQ35571830-E9AA686E-6B76-482C-9DFD-A895C0C0A140Q35624711-C54F09B6-BC8F-4426-81B7-B09742BC3F8EQ35814800-3635DBDE-13CD-4677-B75A-267F05053B51Q36237764-44404B34-9F4B-4781-939B-B9B593179CB2Q36416614-85FA09A0-F356-4EB5-985C-161DAC8FF04FQ36747541-00259185-93B9-4B6F-8B3A-D09683DC22A3Q37035153-40E309F8-EE92-49B4-AFC0-49E1CC3C4FDAQ37270281-1EBD7D96-E8C8-4E30-8FDB-FFCB4E1682E8Q37383372-47C4E27A-8A2C-4AFA-AB80-C15565734F4CQ38867031-AFA7D885-8AD3-4588-8093-A4EE0B5862C6Q38956717-D60AB955-719E-4DAA-B11D-78991D70ACC3Q39095568-0364FCE6-712A-45B1-94DF-7C9B84943FDDQ40108180-864A5E3C-060B-434A-8547-D0815A894B47Q45067817-EB42A3A4-5B77-495A-9B69-00055B72202CQ47191893-0FCF53D8-601B-46C0-930B-2754D97B6D0EQ51049676-938F4A45-DB48-4BD7-8DCC-D63A86383C70Q55025391-68407B9C-99D4-4309-AEB8-9120DA069D2CQ57193549-1D924B4D-F1B2-4095-BDBF-BC6BD1D6F4EDQ58751408-28786B4C-70FE-4100-B6E5-0289F7B191E3
P2860
Prevalence of and risk factors for non-alcoholic fatty liver disease in a non-obese Japanese population, 2011-2012.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Prevalence of and risk factors ...... apanese population, 2011-2012.
@en
Prevalence of and risk factors ...... apanese population, 2011-2012.
@nl
type
label
Prevalence of and risk factors ...... apanese population, 2011-2012.
@en
Prevalence of and risk factors ...... apanese population, 2011-2012.
@nl
prefLabel
Prevalence of and risk factors ...... apanese population, 2011-2012.
@en
Prevalence of and risk factors ...... apanese population, 2011-2012.
@nl
P2093
P2860
P1476
Prevalence of and risk factors ...... apanese population, 2011-2012.
@en
P2093
Kanji Yamaguchi
Kenichi Nishioji
Mai Kamaguchi
Masao Kobayashi
Naomi Mochizuki
Takeshi Nishimura
Yoshio Sumida
Yoshito Itoh
P2860
P304
P356
10.1007/S00535-014-0948-9
P577
2014-03-12T00:00:00Z